Episode 16: The Golden Age of Lupus Nephritis

Dr. Brad Rovin, director of the Division of Nephrology and the Vice Chair of Research in Internal Medicine at the Ohio State University, discusses recent advances in lupus nephritis treatment. Dr. Rovin is deputy editor of Kidney International and the co-chair of glomerular disease guidelines for KDIGO. He has published many major landmark nephrology clinical trials in lupus nephritis (listed below), which he highlights in this episode. It's the "golden age" of lupus nephritis treatment!  Papers we discuss: BLISS (Belimumab) https://www.nejm.org/doi/full/10.1056/NEJMoa2001180  AURORA (Voclosporin) https://www.thelancet.com/article/S0140-6736(21)00578-X/fulltext  LUNAR (Rituximab) https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.34359  NOBILITY (Obinutuzumab) https://ard.bmj.com/content/81/1/100  TULIP-LN (Anifrolumab) https://ard.bmj.com/content/81/4/496  Also check out https://kidney.wiki/ pediatric nephrology platform created by Ryan Town, a fellow from Stanford!